multidisciplinary approach to systemic autoimmune disease

INTERNATIONAL
SYMPOSIUM
MULTIDISCIPLINARY
APPROACH TO SYSTEMIC
AUTOIMMUNE DISEASE
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK
GERMANY
MAY 5TH – MAY 7TH, 2017
Content
MULTIDISCIPLINARY
APPROACH TO SYSTEMIC
AUTOIMMUNE DISEASE
2
CONTENT
Welcome............................................................................................................. 5
Scientific programme.......................................................................................... 6
Registration....................................................................................................... 11
Directions.......................................................................................................... 12
Transportation services...................................................................................... 13
Option 1: Basic bus shuttle service............................................................... 13
Option 2: Extended bus shuttle service........................................................ 13
Option 3: Extended bus shuttle service........................................................ 13
Hotel.................................................................................................................. 14
Social programme.............................................................................................. 15
Get-together – dinner at Hotel Schwanen, Köngen....................................... 15
Meet the chairmen and speakers at Burg Teck.............................................. 15
About Mayo Clinic............................................................................................. 16
Faculty............................................................................................................... 17
Sponsors ........................................................................................................... 34
Further information............................................................................................ 36
Registration form............................................................................................... 39
.
.
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK, GERMANY
MAY 5TH – MAY 7TH, 2017
Preface of the District Council
Text is coming ...
3
VERTRAUEN HEISST
JETZT MEDIUS.
NEUER NAME - VERTRAUTE STÄRKEN:
DIE KREISKLINIKEN ESSLINGEN HEISSEN
JETZT MEDIUS KLINIKEN
WELCOME
The Vaskulitiszentrum Süd Tübingen-Kirchheim, Germany and Mayo Clinic, USA
are pleased to announce a unique 2 1/2-day conference for clinicians, researchers and trainees with a common interest in the aetiology, diagnosis and management of multi-system disorders. The conference will be held on May 5th to
7th, 2017 in the conference center “Schlossberghalle” in Dettingen, a suburb
of Kirchheim-Teck close to Stuttgart. We invite students, trainees, researchers,
consultant physicians / surgeons /pathologists and other health professionals
with an interest in multi-system diseases including vasculitis, interstitial lung
diseases, collagen vascular diseases, and inflammatory ophthalmic and renal
disease to attend. Emphasis will be on cross-discipline collaboration in advancing the field.
Welcome
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK, GERMANY
MAY 5TH – MAY 7TH, 2017
COURSE DIRECTORS:
Ulrich Specks
Connor Group Foundation Professor of Medicine, Chair,
Division of Pulmonary & Critical Care Medicine, Mayo
Clinic College of Medicine, Rochester, MN, USA
Jörg Henes
PD Dr. med., Section Chair Rheumatology, Medizinische
Klinik II, Universitätsklinikum Tübingen, Tübingen, Germany
Bernhard Hellmich
Prof. Dr. med., Chair, Klinik für Innere Medizin, Rheumatologie und Immunologie, Vaskulitiszentrum Süd, medius
KLINIK KIRCHHEIM, Akademisches Lehrkrankenhaus
Universität Tübingen, Kirchheim/Teck, Germany
5
Scientific programme
MULTIDISCIPLINARY
APPROACH TO SYSTEMIC
AUTOIMMUNE DISEASE
SCIENTIFIC PROGRAMME
Friday May 5th, AFTERNOON
15:00 Get together Schlossberghalle
15:30 Welcome and Introduction
U. Specks, B. Hellmich
NEWS IN NEPHROLOGY
Current approaches to diagnosis of renal diseases
Chairs: V. Torres, D. Alscher
15:45 Glomerulonephritis - pathology for the practicing clinician – S. Sethi
16:15 Polycystic kidney disease: from bench to bedside – V. Torres
16:45 Coffee break
Glomerulonephritis: What is new?
Chairs: F. C. Fervenza, N. Heyne
17:15
17:45
18:15
18:45
Membranous nephropathy - a recent paradigm shift – F. C. Fervenza
Membranoproliferative glomerulonephritis - practical implications of recent discoveries – S. Sethi
Biologic variables affecting renal outcomes in lupus nephritis –
F.C. Fervenza
Managing alveolar hemorrhage in pulmonary-renal syndromes –
U. Specks
Optional:
19:20 Bus transfer to Hotel Schwanen, Köngen
19:45 Reception Hotel Schwanen, Köngen
20:15 Dinner Hotel Schwanen, Köngen
6
Saturday May 6th, MORNING
RHEUMATOLOGY & MORE
Recent advances in rheumatology
Chairs: S.R. Ytterberg, C. Fiehn
09:00
09:30
10:00
10:30
Diagnosis and management of polymyositis / dermatomyositis / anti-
synthetase syndrome – S.R. Ytterberg
Hot topics in the management of rheumatoid arthritis – E.L. Matteson
What’s new in the management of scleroderma – S.R.Ytterberg
Coffee break
Scientific programme
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK, GERMANY
MAY 5TH – MAY 7TH, 2017
Novel approaches to treatment and diagnosis
Chairs: N. Leung, R. Meyer
11:00
11:30
12:00
12:30
13:00
Guideline approach to diagnosis of PAH including screening in pati
ents with Scleroderma – C.D. Burger
Management of refractory autoimmune diseases: the role of antimyeloma therapies – N. Leung
Autologous stem cell transplantation in scleroderma: what have we learnt so far? – J. Henes
Ophthalmology of autoimmune disease – J. A. Garrity
Lunch break
7
Scientific programme
MULTIDISCIPLINARY
APPROACH TO SYSTEMIC
AUTOIMMUNE DISEASE
Saturday May 6th, AFTERNOON
RESPIRATORY ROUND-UP
Interstitial lung diseases
Chairs: A. H. Limper, J. Hetzel
14:00
14:30
15:00
15:30
Interstitial lung disease (ILD): terminology, pattern recognition and their practical implications – A.H. Limper
Connective tissue disorder associated ILD: RA, scleroderma, PM/DM – E.L. Matteson
Management of IPF: trial results and daily practice – A.H. Limper
Coffee break
Management of difficult to treat pulmonary –
diseases and complications
Chairs: U. Specks, M. Kohlhäufl
16:00
16:30
17:00
17:30
Update in PAH treatment: More is better – C.D. Burger
Pneumocystis pneumonia - what everybody needs to know about it – A.H. Limper
Asthma, Eosinophilia, and systemic disease: clues for differential diag
nosis and treatment – B. Hellmich
CPC format case discussions with faculty (local residents present local cases –“stump the chumps”)
Optional:
18:30 Bus transfer and walk to Burg Teck
19:30 Dinner at Burg Teck
8
Sunday May 7th, MORNING
VASCULITIS REVISITED
Vasculitis I
Chairs: E. Matteson, B. Hellmich
09:00
09:30
10:00
10:30
Update on diagnosis and management of large vessel vasculitis –
E.L. Matteson
ANCA diagnostics: state of the art – E. Csernok
Treatment of ANCA-associated vasculitis in 2017 – U. Specks
Coffee break
Scientific programme
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK, GERMANY
MAY 5TH – MAY 7TH, 2017
Vasculitis II
Chairs: U. Specks, J. Henes
11:00
11:30
12:00
13:00
13:15
Lessons from the RAVE trial – beyond the headlines – U. Specks
What‘s new in treating patients with Behcet’s disease – T. Xenitidis
CPC format case discussions with faculty (local residents present local cases –“stump the chumps”)
Wrap-up
Farewell lunch
9
Universitätsklinikum
Kompetenz
Tübingen
mit Herz
www.uniklinikum-tuebingen.de
Ihre Karrierewege an Klinikum & Medizinischer Fakultät
www.medizin.uni-tuebingen.de/Mitarbeiter/Karriere
REGISTRATION
SYMPOSIUM MULTIDISCIPLINARY APPROACH TO SYSTEMIC
AUTOIMMUNE DISEASE 2017 - „MAYO CLINIC DAYS 2017“
Number: Date: Location: Registration
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK, GERMANY
MAY 5TH – MAY 7TH, 2017
A171-41012
Friday, May 5th, 2017, 3pm
to Sunday, May 7th, 2017, 2pm
Schlossberghalle, Dettingen/Teck, Germany
Costs:
Advance Registration EUR 149 (until March 1st, 2017)
Late Registration
EUR 190 (from March 1st, 2017)
What is included in the conference fee?
Admission to all scientific sessions
Admission to the industry exhibition
Your own abstract booklet with key slides from all presentations
Catering with lunch, snacks and drinks
Additional services (for details see the following pages)
Transportation services
Hotel reservation
Social programme
Please register using the form at the end of this booklet or our congress-homepage (http://akademie.kk-es.de/autoimmune-conference-2017/).
11
Directions
MULTIDISCIPLINARY
APPROACH TO SYSTEMIC
AUTOIMMUNE DISEASE
DIRECTIONS
LocationAddress
Schlossberghalle:
Teckstraße 35, 73265 Dettingen unter Teck
Hotel Schwanen:
Schwanenstraße 1, 73257 Köngen
Burg Teck:
Teckstraße 100, 73277 Owen
Best Western Hotel: Europastraße 13, 72622 Nürtingen
Distance
0 km
15 km
6 km
18 km
How to get there by car:
Coming from the A8 motorway, take exit 57 (Kirchheim Teck-Ost). Direction Dettingen unter Teck on the B465. Follow the signs to the Schossberghalle. There are
ample parking spaces at the Schlossberghalle.
Access by train and bus: (You can find your connection under www.efa-bw.de)
The train station Kirchheim has connection to Stuttgart with the S1 line. At the central bus station there is a connection to the Schlossberghalle with the bus line 175
or regional bus line RBS 176. The stop is directly in front of the Schlossberghalle.
By plane:
There are three options for you. Use a taxi (distance: approx. 25 km), use the express bus connection line X10 (destination Kirchheim, duration 40 minutes) or use
the S-Bahn train to Stuttgart (continue by train and bus, duration 1:40 hours).
12
TRANSPORTATION SERVICES
Transportation services are not included. But don´t worry - you can book our
additional shuttle services between hotel, conference location and our social
events easily. Please tick the appropriate box on the registration form, if you
want to book one of the following services:
OPTION 1: BASIC BUS SHUTTLE SERVICEEUR 40
We offer you a bus shuttle service on all 3 conference days between the Best
Western Hotel, Nürtingen and our conference location in Dettingen. Our bus
will pick you up in the morning and bring you back at the end of the day.
Transportation services
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK, GERMANY
MAY 5TH – MAY 7TH, 2017
OPTION 2: EXTENDED BUS SHUTTLE SERVICEEUR 10
If you want to join our social event on Friday evening at Hotel Schwanen in
Köngen we will organize your transport from the conference location Dettingen
to Köngen and then back to the Best Western Hotel in Nürtingen.
OPTION 3: EXTENDED BUS SHUTTLE SERVICEEUR 10
Also for the social event on Saturday evening on Burg Teck we offer you a shuttle service. We will bring you from our conference location in Dettingen to the
parking lot where we start our walk up to Burg Teck. After the event we bring
you back to Dettingen. If you need transportation back to the hotel we will gladly bring you there.
There is also the possibility for people with physical limitations to book a „doorto-door“-shuttle. With this add on you won´t have to walk up to Burg Teck. This
service is free but can only be used by a limited amount of people (included in
the price for Option 3, just tick the box on the registration form for the „addon-service“).
13
Hotel
MULTIDISCIPLINARY
APPROACH TO SYSTEMIC
AUTOIMMUNE DISEASE
HOTEL
For accommodation we recommend the Best Western Hotel in Nürtingen. We
reserved a special contingent of double and single rooms for all participants
of the event. If you want to book one of these rooms please contact the hotel
directly and use keyword and contingent number for booking (see below).
BEST WESTERN Hotel
Am Schlossberg in Nürtingen
Keyword: „Autoimmunity Kirchheim 2017“
Contingent number: 1164
[email protected]
Fax: +49 7022 704-346
You`ll find the registration form for the hotel booking at the end of this booklet.
ADDRESS:
BEST WESTERN Hotel
Am Schlossberg in Nürtingen
Europastraße 13
72622 Nürtingen
14
SOCIAL PROGRAMME
GET-TOGETHER – DINNER AT HOTEL SCHWANEN, KÖNGEN
If you don´t want to sit alone in your room on Friday evening (May 5th), you´ll
have the chance to join our get-together dinner at Hotel Schwanen. Have a nice
meal and some good conversation with your colleagues.
Social programme
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK, GERMANY
MAY 5TH – MAY 7TH, 2017
Price: EUR 50 (incl. four-course meal, excl. drinks)
OPTIONAL
Bus shuttle (Option 2): EUR 10 (Dettingen - Köngen - Best Western Nürtingen)
MEET THE CHAIRMEN AND SPEAKERS AT BURG TECK
All day long we saw the impressive Burg Teck from our congress location. On
Saturday evening we do some exercise to take a closer look at this medieval
castle. After a short bus transfer we make our way up. While walking up an romantic path to Burg Teck (approx. 40 min) you´ll enjoy the marvelous landscape
of the Swabian Alb and its surroundings.
On the top (about 775 m above sea level) we´ll find the legendary Burg Teck.
Archaeological finds prove its existence since the 11th century. In this historical
atmosphere we enjoy a traditional swabian meal and music from the middle-age. Here you have the possibility to meet the speakers of the event and
get connected with your colleagues.Then after a tasty and enjoyable evening
we do our walk back - be prepared for some adventure.
Price: EUR 60 (incl. meal, excl. drinks)
OPTIONAL
Extended bus shuttle service: EUR 10 (Dettingen - Teck - Dettingen - Best
Western Nürtingen)
Please note:
Highly recommended are good shoes (e.g. sneakers). For people who aren´t
able to walk this distance we arranged a special shuttle service. Please consider this option during the booking procedure (add on to Option 3).
15
About Mayo Clinic
MULTIDISCIPLINARY
APPROACH TO SYSTEMIC
AUTOIMMUNE DISEASE
ABOUT MAYO CLINIC
Mayo Clinic is a nonprofit medical practice and medical research group based in Rochester, Minnesota. It
employs more than 4,500 physicians and scientists
and 57,100 allied health staff. The practice specializes
in treating difficult cases through tertiary care. Each
year, more than 1.3 million patients from all 50 states
and from more than 150 countries are seen at one
of the Mayo Clinic facilities. Mayo Clinic offers highly
specialized medical care, and a large portion of the patient population are referrals from smaller clinics and
hospitals from across the upper Midwest and the United States as a whole.
Mayo Clinic researchers contribute to the understanding of disease processes,
best clinical practices, and translation of findings from the laboratory to the
clinical practice. Nearly 600 doctoral level physicians and research scientists
are employed, with an additional 3,400 other health personnel and students
with appointments in research. In 2015, more than 2,700 research protocols
were reviewed by the Mayo Clinic Institutional review board and 11,000 ongoing human research studies. These research initiatives led to more than 7,300
research publications and review articles in peer-review journals. It spends over
$660 million a year on research.
William Worrall Mayo settled his family in Rochester in 1864 and opened a
medical practice that evolved under his sons into Mayo Clinic. Mayo Clinic is
widely regarded as one of the United States‘ greatest hospitals and ranked No.
1 in the country] on the 2016–2017 U.S. News & World Report List of „Best
Hospitals“ of the United States, maintaining a position near the top for more
than 25 years. It has been on the list of „100 Best Companies to Work For“
published by Fortune magazine for thirteen consecutive years. It continued to
achieve this ranking through 2015.
In addition to their flagship hospital in Rochester, the Mayo Clinic has major
campuses in Arizona and Florida. The Mayo Clinic Health System also operates
affiliated facilities throughout Minnesota, Wisconsin, and Iowa.
Source: https://en.wikipedia.org/wiki/Mayo_Clinic
16
FACULTY
DOMINIK ALSCHER
Faculty
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK, GERMANY
MAY 55TH
– MAY
– MAY
7, 2017
7TH, 2017
Professor of Medicine, Chair, Klinik für Nephrologie,
Robert-Bosch-Krankenhaus, Stuttgart, Germany
Dr. Mark Dominik Alscher is the executive chief physician of the Robert-Bosch-Hospitals, a group of hospitals in South Germany. Additionally he is chief of the
department of Nephrology, General Internal Medicine
and Emergencies. He has published over 180 scientific
papers in the areas of peritoneal dialysis, acute kidney
failure and medical knowledge systems. He is author of
several chapter in textbooks of nephrology in Germany.
Additionally he is the president of the German Society
of Nephrology, president of the Southwest-Germany
Society of Internal Medicine and member of working
groups regarding quality assurance in dialysis, telemedicine, certification of hospitals and local member groups.
CHARLES D. BURGER
Professor of Medicine, Division of Allergy and Pulmonary Medicine, Mayo Clinic College of Medicine, Jacksonville, FL, USA
Dr. Burger is a graduate of the Wake Forest School of
Medicine, completed his Internal Medicine Residency
at Vanderbilt University and Pulmonary & Critical Care
Medicine fellowship at the Mayo Clinic, Rochester Minnesota. He’s been on the faculty at the Mayo Clinic in
Jacksonville Florida since 1991 and is currently Professor of Medicine at the Mayo Clinic School of Medicine
and Science. He is Medical Director of the accredited
Pulmonary Vascular Center and is past Chair of the Division of Pulmonary & Critical Care Medicine at the Mayo
Clinic in Jacksonville Florida.
His primary clinical and research interest has been pulmonary arterial hypertension (PAH), principally diagno-
17
Faculty
MULTIDISCIPLINARY
APPROACH TO SYSTEMIC
AUTOIMMUNE DISEASE
sis, treatment and prognosis. Substantial contributions
to the literature include the role of screening for associated conditions, pharmaceutical treatment trials, and understanding the appreciable burden of hospitalization in
patients with PAH. More recently investigation of overall
healthcare burden of PAH has been an area of additional
inquiry.
ELENA CSERNOK
Reference Laboratory for Vasculitis Autoimmune Serology, Klinik für Innere Medizin, Rheumatologie und Immunologie, medius KLINIK KIRCHHEIM, Akademisches
Lehrkrankenhaus der Universität Tübingen, Germany
Dr. Elena Csernok, former head of the Vasculitis Diagnostic and Research Unit at the Department of Rheumatology and Immunology, Klinikum Bad Bramstedt,
University of Lübeck, is specialized in immunology
and rheumatology with main activities in clinical immunology and translational medicine within the field
of autoimmune diseases. She graduated from the
University of Iasi and received her PhD from the University of Lübeck, Germany. Her work focuses on clinical
immunology and vasculitis and began in the mid-eighties when she proceeded many projects investigating
immunopathology of ANCA-associated vasculitides,
especially granulomatosis with polyangiitis („Wegener`s
granulomatosis“). After retirement from full-time work
she is active in immunodiagnostic studies focused on
rheumatic disorders, especially in the vasculitis field,
and participates in development of effective and innovative methods for ANCA diagnostic.
FERNANDO C. FERVENZA
M.D., Ph.D. Professor of Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, MN, USA
Fernando C. Fervenza, MD. D.Phil (Oxon – Jesus College). Is a Professor of Medicine at the Mayo Graduate
18
School of Medicine, Rochester, MN, USA. He graduated
in Medicine at the Pontificia Universidade Catolica do
Rio Grande do Sul, Brasil. He underwent his clinical
nephrology training at the Oxford Renal Unit from 1985
to 1991. Subsequent training included Post-doctoral Fellowship at Stanford University, USA (1993-1997). He is
a Fellow of the American Society of Nephrology, Fellow
of the American College of Physicians, past Member of
the American Board of Internal Medicine, Nephrology
section, Associate Editor of the Journal of the American of Nephrology and Up-To-Date Section Editor for
Glomerular Disease. His area of interest is in pursuing
patient-oriented research projects aiming to bring new
bench research discoveries to the bedside treatment of
patient with glomerular diseases.
Faculty
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK, GERMANY
MAY 55TH
– MAY
– MAY
7, 2017
7TH, 2017
CHRISTOPH FIEHN
Professor of Medicine, Chair, Klinik für Rheumatologie,
ACURA Kliniken, Baden-Baden, Germany
Christoph Fiehn, Prof. Dr. med, is Medical Director of
the Department for Rheumatic Diseases Baden-Baden
since 2004. He graduated at the University of Heidelberg in 1991. After serveral years of national and international experience in rheumatology he got his habilitation
from the University of Heidelberg in 2004.
Prof. Fiehn is scientifically well represented in his field,
with many peer-reviewed publications respectively, and
renowned in Germany as well as internationally. His
scientific and clinical interests include gerontorheumatolgoy, the modern therapy of rheumatoid arthritis,
clinical pharmacology of methotrexate and systemic
lupus erythematosus.
Christoph Fiehn is a member of several societies and
expert working groups. In 2013, as a member of the
working group “Rheumatological Specialist Assistance”
Prof. Dr. Christoph Fiehn, received the Kußmaul Medal
of the German Society of Rheumatology for special
merits in Rheumatology.
19
MabThera ist mehr. Die zielgerichtete B-Zell-Therapie
bei ANCA-assoziierter Vaskulitis1.
von
nach
Signifikant besseres Ansprechen bei Patienten
mit Rezidiv2 bzw. PR3-AAV Positivität3
Vorteil durch CYC-Einsparung unter MabThera®4:
erhöhtes Tumorrisiko vermeiden, Fertilitätserhalt
1
Zugelassen in Kombination mit Glucocorticoiden zur Remissionsinduktion bei erwachsenen Patienten mit schwerer, aktiver Granulomatose mit Polyangiitis
und Mikroskopischer Polyangiitis. 2 Stone JH, Merkel PA, Spiera R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med
2010;363:221–32. 3 S. Unizony et al. Ann Rheum Dis 2015;0:1–4; 4 F. Moosig et al. Dtsch Med Wochenschr 2014;139:2248-2253
Bezeichnung des Arzneimittels: MabThera® 100 mg/500 mg Konzentrat zur Herstellung einer Infusionslösung. Wirkstoff: Rituximab, ein gentechn. hergest. monoklon. chimärer Antikörper der
Klasse IgG. Zusammensetzung: Eine Durchstechfl. MabThera enthält: 100 mg/10 ml bzw. 500 mg/50 ml Rituximab. Sonst. Bestandteile: Natriumcitrat, Polysorbat 80, Natriumchlorid, Salzsäure,
Natriumhydroxid, Wasser für Injekt.zwecke. Anwendungsgebiete: MabThera in Komb. mit Methotrexat ist für die Behandl. erw. Pat. mit schwerer aktiver rheumatoider Arthritis angezeigt, die
ungenügend auf andere krankheitsmodifizierende Antirheumatika (DMARDs) einschl. einer oder mehrerer Ther. mit Tumornekrosefaktor(TNF)-Hemmern angesprochen oder diese nicht vertragen
haben. MabThera® in Komb. mit Methotrexat vermindert das Fortschreiten der radiologisch nachweisbaren Gelenkschädigung u. verbessert die körperliche Funktionsfähigkeit. MabThera in Komb. mit
Glukokortikoiden wird angewendet zur Induktion einer Remission bei erw. Pat. mit schwerer, aktiver Granulomatose mit Polyangiitis (Wegenersche Granulomatose) (GPA) u. mikroskopischer Polyangiitis (MPA). Gegenanzeigen: Überempfindl. gg. den Wirkstoff, gg. Mausproteine od. einen der sonst. Bestandt. des AM. Aktive, schwere Infekt., stark geschwächtes Immunsystem, schwere Herzinsuff.
(NYHA Klasse IV) od. schwere, unkontrollierte Herzerkrank. Nebenwirkungen: Infusionsbed. NW einschl. Schmerz. an der Infus.-stelle, allergische Reakt. (bei Indikation Autoimmunerkrank. auch bis
zu 24 h nach der Infus.), die auch mit einer Verschlecht. bestehender Herzerkrank.verbunden sein können. Bakterielle od. virale Infekt. wie Sepsis, Pneumonie, Atemwegsinfekt., Herpes zoster, Hepatitis
B, Harnwegsinfekt., Pilzinfekt. (verurs. z. B. durch Pneumocystis jirovecii), Hepatitis-B-Reaktivierung (einige mit tödlichem Ausgang). Sehr selten: PML, die tödlich verlief. Schwere Hautreakt. wie SJS
od. TEN (einige mit tödlichem Ausgang). Indikation Autoimmunerkrank: Blutdruckveränd., erhöhter Blutdruck, Übelkeit, Hautreakt., Ausschlag, Erröten (mit Hitzegefühl), Hautausschlag einschl. Akne
od. Flecken auf der Haut, Juckreiz, Urtikaria, Fieber, Rhinitis, Zittern, Tremor, beschl. Herzschlag, Änd. des Herzrhythmus, Müdigkeit, Kopfschmerzen, Sinusitis, Schmerzen im Bauch, Rücken, in Muskeln,
Händen, Füßen u./od. Gelenken, Erbrechen, Verdauungsstör., Sodbrennen, Durchfall, Verstopfung, Reizg. u./od. Geschwüre im Mund od. Rachen, Atemprobleme, Tinea pedis, Hypercholesterinämie,
Parästhesie, Ischialgie, Migräne, Benommenheit, Schwindel, Alopezie, Depression, Angstgefühl, Ödeme, Entz./Reizg. u./od. Engegefühl der Lunge u. Rachen, Husten, Kurzatmigkeit, Komplex von
Krankheitserschein. einige Wo. nach Infus., die einer Allergie ähneln, Neutropenie, vermind. Immunglobulinspiegel, verstopfte Nase, Nasenbluten, Muskelverspannung, Muskelzuckungen od. -zittern,
niedrige Anzahl weißer Blutzellen u./od. Blutplättchen, Insomnia, Schwellungen an Händen od. Knöcheln, Anstieg der Kaliummenge im Blut, Anämie. Indikation NHL/CLL: Sehr häufig: bakterielle od.
virale Infekt., Entzündung der Bronchien (Bronchitis), geringe Anzahl an weißen Blutkörperchen (mit od. ohne Fieber) od. Blutplättchen, Übelkeit, Alopezie, Schüttelfrost, Kopfschmerzen, verminderte
Immunabwehr. Häufig: Sepsis, Lungenentzündung, Herpes, Erkältungen, Infekt. der Bronchien, Pilzinfekt., Infekt. unbekannten Ursprungs, Sinusitis, Hepatitis B, Anämie, Panzytopenie, Überempfindl.,
hohe Blutzuckerwerte, Gewichtsverlust, Schwellungen im Gesicht u. am Körper, erhöhte LDH Werte, erniedrigte Serumkalziumwerte, Parästhesie, Unruhe, Einschlafschwierigkeiten, Vasodilatation,
Schwindel, Angstgefühl, erhöhte Tränenbildung, Stör. der Tränensekretion u. -bildung, Konjunktivitis, Ohrgeräusche u. -schmerzen, Herzinfarkt, unregelm. od. erhöhte Herzfrequenz, Hypertonie,
Hypotonie einschl. orthostatische, Bronchospasmus, Entzündung/Reizung der Lungen/Nasennebenhöhlen od. im Rachen, Atemnot, laufende Nase, Erbrechen, Durchfall, Abdominalschmerzen, Reizung
u./od. Geschwürbildung in Rachen u. Mund, Schluckbeschwerden, Verstopfung, Verdauungsstör., Essstör., Nesselsucht, verstärktes Schwitzen, Nachtschweiß, Myalgie, Gelenk-, Muskel-, Rücken- u.
Nackenschmerzen, allgemeines Unwohlsein od. Unbehagen od. Müdigkeit, Zittern, Anzeichen einer Grippe, Multiorganversagen. Gelegentlich: Gerinnungsstör., aplastische hämolytische Anämie,
geschwollene/vergrößerte Lymphknoten, düstere Gemütslage, Depression, Nervosität, Stör. der Geschmacksempfindung, Angina pectoris, Asthma, Sauerstoffmangel, Vergrößerung des Bauchraums.
Sehr selten: erhöhte IgM-Antikörperspiegel, Stör. der Blutchemie, verursacht durch den Abbau absterbender Krebszellen, periphere Neuropathie, Gesichtslähmung, Herzinsuff., Gefäßentzündungen
auch mit Hautveränderungen, Atemversagen, Darmwandperforation, schwere, potenziell lebensbedrohliche Hauterkrank. mit Blasenbildung, Nierenversagen, schwerer Sehverlust. Nicht bekannt: verzögerte Verminderung der weißen Blutzellen, infusionsbedingte sofortige Abnahme der Blutplättchen (auch mit tödlichem Verlauf), Gehörverlust, Verlust anderer Sinne. Veränderungen von Laborwerten.
Dosierung: Rheumatoide Arthritis: zwei i.v. Infus. zu je 1000 mg im Abstand von zwei Wo. Weitere Behandl.-zyklen sind möglich. Die Notwendigkeit weiterer Behandl.-zyklen sollte 24 Wo. nach
dem vorherigen Zyklus beurteilt werden. Granulomatose mit Polyangiitis u. mikroskopische Polyangiitis: zur Induktion einer Remissionsther. beträgt die Dosierung 375 mg/m2 KOF 1x wöchentl. als i.v.
Infus. über einen Zeitraum von vier Wo. (insgesamt 4 Infus.) in Komb. mit Glukokortikoiden. Prämedikation: Prämed. mit Analgetikum, Antihistaminikum, Glukokortikoiden gem. Fachinformation
beachten. Verschreibungspflichtig. Hinweise der Fachinformation beachten. Pharmazeutischer Unternehmer: Roche Registration Limited, UK-Welwyn Garden City. Weitere Informationen auf
Anfrage erhältlich. Vertreter in Deutschland: Roche Pharma AG, 79630 Grenzach-Wyhlen. Stand der Information: Mai 2016.
JAMES A. GARRITY
M.D. Professor of Ophthalmology, Department of Ophtalmology, Mayo Clinic College of Medicine, Rochester,
MN, USA
Faculty
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK, GERMANY
MAY 55TH
– MAY
– MAY
7, 2017
7TH, 2017
James A. Garrity received both a B.S. (Biochemistry)
in 1976 and his M.D. in 1980 from the University of
Minnesota (Minneapolis, Minnesota). After internship at
Hennepin County Medical Center in Minneapolis, Garrity pursued residency training in ophthalmology at the
Mayo Clinic and subspecialty training in neuro-ophthalmology and orbital surgery at University of Pittsburgh
– Allegheny General Hospital (Pittsburgh, Pennsylvania).
Garrity joined the Department of Ophthalmology at
Mayo Clinic Rochester in 1986. He is the Whitney and
Betty MacMillan Professor of Ophthalmology in the
Mayo Medical School. In 1988 and 1995 Garrity received
the Mayo Foundation Teacher of the Year Award for the
Department of Ophthalmology, the Honor Award (1994)
and Senior Honor Award (2006) from the American
Academy of Ophthalmology. He was recognized as the
Distinguished Mayo Clinic Clinician in 1999. He is the
author or coauthor of more than 100 publications and is
a scientific reviewer for several peer-review journals. His
clinical practice and research interests involve Graves’
ophthalmopathy and orbital diseases.
BERNHARD HELLMICH
Professor of Medicine, Chair, Klinik für Innere Medizin, Rheumatologie und Immunologie, medius KLINIK
KIRCHHEIM, Akademisches Lehrkrankenhaus der Universität Tübingen, Germany
Bernhard Hellmich, Dr. med., is Professor of Medicine at
the University of Tübingen and Chair of the Department
of Internal Medicine, Rheumatology and Immunology
at the medius KLINIK KIRCHHEIM, Teaching Hospital
of the University of Tübingen. He is Co-Director of the
Vasculitis Center Tübingen-Kirchheim.
21
Faculty
MULTIDISCIPLINARY
APPROACH TO SYSTEMIC
AUTOIMMUNE DISEASE
Prof. Hellmich received his MD degree at the University
of Bochum, Germany. He completed his internal medicine residency at the Department of Medicine at the
University Hospital Bergmannsheil in Bochum and his
rheumatology training at the Rheumaklinik Bad Bramstedt and University of Lübeck. From 2002 - 2007 he
was vice-chair of the department of rheumatology at the
Rheumaklinik Bad Bramstedt and University of Lübeck.
Prof. Hellmich’s clinical and research interests are in the
field of vasculitis. He is clinical chair of the reference laboratory for ANCA-diagnostics at medius KLINIK KIRCHHEIM and is actively involved in multicenter clinical trials
and cohort studies in different forms of vasculitis. Prof.
Hellmich is lead author of the EULAR recommendations
for conducting clinical trials and vasculitis and coauthor
of the EULAR/ERA recommendations for management
of small- and large vessel vasculitis and the 2017 German
S-1 Guidelines for management of AAV.
JÖRG HENES
Rheumatology Unit, Medizinische Klinik II, Universitätsklinikum Tübingen, Germany
Joerg C. Henes M.D., P.h.D, is head of the division of
rheumatology in the Department of Internal Medicine II
at the University Hospital Tuebingen. He also is director
of the Centre for Interdisciplinary Clinical Immunology,
Rheumatology and Auto-inflammatory Diseases – INDIRA - at the University Hospital Tuebingen
Dr. Henes received the M.D. and P.h.D degree from the
Eberhard Karls University Tuebingen.
His clinical and research interests are in the field of
systemic sclerosis and vasculitis, especially in the treatment option with autologous stem cell transplantation
and in fertility and pregnancy in patients with rheumatic
diseases.
22
JÜRGEN HETZEL
Sektion Pneumologie, Medizinische Klinik II, Universitätsklinikum Tübingen, Germany
Juergen Hetzel, M.D. is Associate Professor at the University Clinic of Tübingen. Dr. Hetzel received the M.D.
degree from University of Ulm. He completed an internship and residency in internal medicine at University of
Ulm. Additionally he qualified in Respiratory Medicine,
Cardiology, Intensive Care Medicine and Sleep Medicine.
Dr. Hetzel’s clinical and research interests are in the
fields of interventional bronchoscopy, interstitial lung
disease and lung cancer.
Faculty
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK, GERMANY
MAY 55TH
– MAY
– MAY
7, 2017
7TH, 2017
NILS HEYNE
Section Chair Nephrology, Medizinische Klinik IV, Universitätsklinikum Tübingen, Germany
Nils Heyne, M.D., is Head of the Section of Nephrology
and Hypertension at Tübingen University Hospital and
Assistant Professor of Internal Medicine at the Eberhard-Karls-Universität Tübingen, Tübingen, Germany.
He received his MD from the University of Tübingen in
1995. After training in experimental and clinical pharmacology, he worked as a resident in internal medicine
before completing a fellowship in renal medicine. He
was appointed Head of the Section of Nephrology and
Hypertension in 2012 and serves as senior nephrologist
at the Tübingen Collaborative Transplant Center.
Nils Heyne is a member of several international societes
and expert working groups. His scientific and clinical
interests include nephroimmunology, transplantation
and renal involvement in systemic disease with focus
on aHUS, multiple myeloma and diabetes.
23
Faculty
MULTIDISCIPLINARY
APPROACH TO SYSTEMIC
AUTOIMMUNE DISEASE
MARTIN KOHLHÄUFL
Professor of Medicine, Chair, Klinik für Pneumologie,
Klinik Schillerhöhe, Robert-Bosch-Krankenhaus, Gerlingen, Germany
Prof. Dr. Martin Kohlhäufl Studied medicine at the
University of Erlangen-Nuernberg and the University of
Pennsylvania, Philadelphia, PA, USA. Prof. Dr. Martin J.
Kohlhäufl received his MD degree from the University
of Erlangen-Nuernberg in 1988. From 1987 to 1995 he
was scientific Assistant at the University Hospital of the
Johannes-Gutenberg-University. From 1987 to 1995 he
was Intern at the Hospital Darmstadt, Teaching Hospital
of the University of Frankfurt and from 1995 to 2002
he was Intern at the Clinic Munich-Gauting, Center for
Pneumology and Thoracic Surgery as well as scientific assistant and medical officer (Head) of the Clinical
Research Group ‚Aerosol Medicine‘ of the Institute for
Inhalational Biology of the GSF-Research Center for
Environment and Health Munich-Neuherberg with sponsorship by the Federal Ministry of Education, Sciences,
Research, and Technology. Since 2006 he was executive
senior Physician at the Asklepios Clinic, Munich-Gauting, Center for Pneumology and Thoracic Surgery. Since
2007 he is Chief Physician at the Hospital Schillerhoehe
Center for Pneumology and Thoracic Surgery at the
Robert-Bosch-Hospital, Stuttgart Academic Teaching
Hospital of the University of Tuebingen.
He is member of many scientific communities (i.e. European Society of Medical Oncology (ESMO), European Respiratory Society, International Society of Aerosols in Medicine) and reviewer for scientific journals (i.e.
European Journal of Pharmaceutical Sciences, American Journal of Respiratory and Critical Care Medicine,
Thorax).
24
NELSON LEUNG
M.D. Professor of Medicine, Division of Nephrology and
Hypertension, Mayo Clinic College of Medicine, Rochester, MN, USA
Faculty
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK, GERMANY
MAY 55TH
– MAY
– MAY
7, 2017
7TH, 2017
Dr. Leung graduated from Creighton University School
of Medicine. He completed his internship at the University of Iowa Hospitals and Clinic. From there, he went
to the Mayo Clinic Rochester where he completed his
residency in Internal Medicine. It is there that he completed his Nephrology fellowship training. He currently
has a joint appointment in the Division of Nephrology
and Hypertension, and the Division of Hematology. He
has an academic rank of professor of Medicine.
His main interest is in monoclonal gammopathy related
kidney diseases. He has written extensively on renal
amyloidosis, myeloma cast nephropathy and monoclonal immunoglobulin deposition disease. He introduced
the concept of monoclonal gammopathy of renal significance and has made substantial contributions in the
treatment of paraprotein related kidney diseases. He
is the current president of the International Kidney and
Monoclonal Gammopathy Research Group.
ANDREW H. LIMPER
Professor of Medicine, Division of Pulmonary & Critical
Care Medicine, MayoClinicCollege of Medicine, Rochester, MN, USA
Dr. Andrew Limper attended the University of Illinois at
Urbana-Champaign, graduating Cum Laude with highest distinction in organic chemistry and physiology in
1980. Dr. Limper subsequently attended the University
of Illinois College of Medicine at Peoria, graduating first
in his class with honorary induction into Alpha Omega Alpha academic fraternity. During his senior year
of Medical School, Dr. Limper received the Spencer
Williamson Award for Excellence in Internal Medicine.
He subsequently completed both Internal Medicine and
25
Janssen-Cilag GmbH
DE/HUG/4616/1059
Der Pen.
Pulmonary-Critical Care training at the Mayo Graduate
School of Medicine in Rochester, Minnesota, receiving
recognition as an Outstanding Achievement Awardee of
the Graduate School of Medicine. Following a research
fellowship at Washington University, Dr. Limper returned to join the staff of Mayo Clinic Rochester where
he has achieved the rank of Professor of Medicine. He
currently serves as Associate Chair of the Department
of Medicine for Research and Director of the Pulmonary
Diseases Research Unit, Professor of Medicine.
Dr. Limper is a clinical expert in interstitial lung diseases, and drug-induced lung diseases, and pulmonary
fungal infections. He has authored in excess of 210
manuscripts, and has mentored dozens of trainees and
junior faculty. Dr. Limper’s research program focuses on
identifying new agents for treatments of lung fibrosis,
as well as improving treatments of lung infections in
immunocompromised patients. He has served as a
frequent consultant to the National Institutes of Health.
He is an elected member of the American Society of
Clinical Investigation, and is Past President of the American Association of Pulmonary and Critical Care Program
Directors. He has received the Distinguished Alumnus
Award from his University of Illinois College of Medicine
in Peoria. Dr. Limper holds two patents related to his
work in pulmonary infection, and continues to seek new
means to diagnose and treat patients with lung fibrosis
and lung infection.
Faculty
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK, GERMANY
MAY 55TH
– MAY
– MAY
7, 2017
7TH, 2017
ERIC L. MATTESON
M.D. Professor of Medicine, Division of Rheumatology,
Mayo Clinic College of Medicine, Rochester, MN, USA
Eric L. Matteson, M.D., M.P.H., is Professor of Medicine
and Emeritus, Division of Rheumatology in the Department of Internal Medicine at Mayo Clinic. He has a joint
appointment in the Division of Epidemiology in the Department of Health Sciences Research and is faculty in
the Clinical & Translational Science program at the Mayo
27
Faculty
MULTIDISCIPLINARY
APPROACH TO SYSTEMIC
AUTOIMMUNE DISEASE
Graduate School.
Dr. Matteson received the M.D. degree from Friedrich-Alexander University at Erlangen-Nurnberg. He
completed an internship and residency in internal medicine at Michigan State University and a fellowship at the
University of Michigan and received the M.P.H. degree
in Public Health in Epidemiology from the University of
North Carolina, Chapel Hill.
Dr. Matteson’s clinical and research interests are in
the fields of vasculitis and inflammatory arthritis. Dr.
Matteson is the current President of the Rheumatology
Research Foundation of the American College of Rheumatology.
RALF MEYER
Chair, Medizinische Klinik II mit Schwerpunkt Hämatologie-Onkologie, St. Johannes Hospital, Dortmund,
Germany
Since May 2014, Priv. Doz. Ralf G. Meyer, MD chairs the
Medical Department II at the St.-Johannes Hospital in
Dortmund (Dpt. of Hematology, Oncology and Gastroenterology). He graduated at the Medical Department /
Institute of the Philips-University Marburg and joined
the University Medical Center Mainz as associate medical doctor in internal medicine.
Dr. Meyer‘s clinical degrees in Internal Medicine as well
as his qualification as specialist for Hematology and
Oncology were certified at the Department of Internal
Medicine III. During his tenure he joined the stem cell
transplant unit which he later took over as chair.
Dr. Meyer was member of cancer research groups
in Immunology at the Department of Immunology in
Marburg and the National Cancer Institute, Frederick,
Maryland, USA. In Mainz, he further specialized in
immune-response analyses and joined the “Tumor-Vaccination Center”. The research group he has established,
focuses on immune-reconstitution following allogeneic
28
stem cell transplantation and the role of antigen-presenting cells in graft-versus-host disease.
In his current responsibility as chief medical officer of
the Johannes hospital, Dortmund, Dr. Meyer mainly focusses on clinical and health service research in Hematology and Oncology. He recently founded the Center
for stem-cell transplantation Dortmund, a cooperation of
3 local institutions to collaborate and excel medical care
for leukaemia and lymphoma patients.
Faculty
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK, GERMANY
MAY 55TH
– MAY
– MAY
7, 2017
7TH, 2017
SANJEEV SETHI
M.D. Ph.D. Professor of Laboratory Medicine and
Pathology, Division of Anatomic Pathology, Mayo Clinic
College of Medicine, Rochester, MN, USA
Dr. Sanjeev Sethi graduated from Assam Medical College, India. He pursued graduate studies thereafter at
Albany Medical College, NY, and received his Ph.D. in
Experimental Pathology in 1995. Subsequently, Dr. Sethi
completed his Clinical and Anatomic Pathology residency at Yale University School of Medicine (1995-1999).
He then went on to complete his fellowship in Renal
Pathology at Brigham and Women’s Hospital, Harvard
University (1999-2001). He is currently a professor at
the Mayo Clinic, Department of Laboratory Medicine
and Pathology, Rochester. His primary interests and
research are in fields of 1) Glomerulonephritis, with a
focus on the approach to glomerulonephritis, the role of
monoclonal gammopathy in glomerulonephritis, and the
role alternative pathway of complement in glomerulonephritis, and 2) Application of proteomics in renal pathology. He has over 175 publications.
29
Akademie Werbung
ULRICH SPECKS
M.D. Professor of Medicine, Chair, Division of Pulmonary & Critical Care Medicine, Mayo Clinic College of
Medicine, Rochester, Minnesota, USA
Faculty
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK, GERMANY
MAY 55TH
– MAY
– MAY
7, 2017
7TH, 2017
Dr. Specks is a graduate of the University of Bonn, Germany, Medical School, completed his Internal Medicine
Residency and Pulmonary & Critical Care Medicine
fellowship at the Mayo Clinic, followed by a post-doctoral fellowship in Biochemistry at the Max-Planck-Institute
in Munich, Germany. He’s been on the faculty at the
Mayo Clinic in Rochester, MN since 1992 and currently
is Professor of Medicine at the Mayo Clinic College
of Medicine and Chair of the Division of Pulmonary &
Critical Care Medicine.
He’s had a long-standing interest in ANCA-associated
vasculitis. These diseases have been the focus of his
clinical activities as well as widely published research.
He’s made substantial contributions to the understanding of the pathogenesis of ANCA-associated vasculitis, the refinement of ANCA test methodologies, our
understanding of optimal clinical applications of ANCA
testing, as well as novel therapies for ANCA-associated
vasculitis. He was the co-principal investigator of the
„Rituximab for ANCA-associated Vascultitis (RAVE)“ tria
VINCENTE E. TORRES
Professor of Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester,
MN, USA
Vicente Torres received MD and Doctoral degrees from
the University of Barcelona and moved to the Mayo
Clinic in 1972 for training. He joined the faculty of the
Mayo Clinic in 1979 and became Professor of Medicine
in 1991 and Robert M. and Billie J. Pirnie Professor of
Kidney Research in 2016. He has served as Chair of
the Division of Nephrology; Director of the NIH funded
Kidney Disease Research Training Grant, on the Sci-
31
Faculty
MULTIDISCIPLINARY
APPROACH TO SYSTEMIC
AUTOIMMUNE DISEASE
entific Advisory Board of the PKD Foundation, and on
several NIH study sections and committees. He directs
the NIH funded Mayo Clinic Robert M. and Billie Kelley
Pirnie Translational Polycystic Kidney Disease Center,
has served as a principal investigator for the NIH funded
CRISP imaging and the HALT-PKD clinical trials, and for
Industry funded clinical trials of vasopressin V2 receptor
antagonists. He received the 2007 Lillian Jean Kaplan
Award for Advancement in the Understanding of PKD
THEODORUS XENITIDIS
Rheumatology Unit, Medizinische Klinik II, Universitätsklinikum Tübingen, Germany
Theodoros Xenitidis M.D., is the deputy head of the
division of rheumatology in the Department of Internal
Medicine II at the University Hospital Tuebingen. He
was coordinating between 2011 and 2013 the Centre
for Interdisciplinary Clinical Immunology, Rheumatology and Auto-inflammatory Diseases – INDIRA - at the
University Hospital Tuebingen
Dr. Xenitidis graduated at the Julius Maximilian University Wuerzburg and received 2012 the M.D. degree from
the Eberhard Karls University Tuebingen.
His clinical and research interests are about the Behcet’s Disease and arthropathies associated with Crohn’s
Disease and Ulcerative Colitis.
STEVEN R. YTTERBERG
Associate Professor of Medicine, Division of Rheumatology, Mayo Clinic College of Medicine, Rochester,
Minnesota, USA
Dr. Ytterberg is a graduate of Jefferson Medical College
of Thomas Jefferson University in Philadelphia, PA. He
completed Internal Medicine residency and was Chief
Medical Resident at Thomas Jefferson University Hospital, followed by Rheumatology fellowship training at the
32
University of Michigan. He was a member of the faculty
of the University of Minnesota and the staff of the Minneapolis Veterans Affairs Medical Center before joining
Mayo Clinic in Rochester, MN in 1998. He is currently
an Associate Professor of Medicine at the Mayo Clinic
College of Medicine.
His clinical and research interests center on vasculitis
and inflammatory myositis. He is a member of the
steering committee of the Vasculitis Clinical Research
Consortium. He has ongoing interests in medical education and has been a member of the Rheumatology
Subspecialty Board of the American Board of Internal
Medicine.
Faculty
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK, GERMANY
MAY 55TH
– MAY
– MAY
7, 2017
7TH, 2017
33
Sponsors
MULTIDISCIPLINARY
APPROACH TO SYSTEMIC
AUTOIMMUNE DISEASE
34
SPONSORS
The organizers wish to thank all sponsors for their generous support of this
scientific meeting.
AbbVie Deutschland
GmbH & Co. KG
Celgene GmbH
Actelion Pharmaceuticals
Deutschland GmbH
GlaxoSmithKline
GmbH & Co. KG
Biogen GmbH
Hexal AG
Boehringer Ingelheim Pharma
GmbH & Co. KG
Janssen-Cilag GmbH
Lilly Deutschland GmbH
ORGENTEC Diagnostika GmbH
medac
Pfizer Pharma GmbH
Mundipharma Deutschland
GmbH & Co. KG
Roche Pharma AG
MSD Sharp & Dohme GmbH
SWEDISH ORPHAN BIOVITRUM
GmbH
Novartis Pharma GmbH
UCB Pharma GmbH
Sponsors
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK, GERMANY
MAY 55TH
– MAY
– MAY
7, 2017
7TH, 2017
35
Further information
MULTIDISCIPLINARY
APPROACH TO SYSTEMIC
AUTOIMMUNE DISEASE
FURTHER INFORMATION
Do you have any questions?
We are at your disposal:
You can access our website at:
http://akademie.kk-es.de/autoimmune-conference-2017/
Here you can find the most up-to-date information so that your successful
participation will not be a thing of the past.
Organization by:
Akademie der medius KLINIKEN
Charlottenstrasse 47
73230 Kirchheim unter Teck
Phone: +49(0) 7021 88 44 800
Fax: +49(0) 7021 88 44 809
E-Mail: [email protected]
Internet: http://akademie.medius-kliniken.de
36
BEST WESTERN Hotel Am Schlossberg · Europastraße 13 · 72622 Nürtingen
Registration from BEST WESTERN Hotel Am Schlossberg in Nürtingen
Please fill in completely and send to [email protected] /
[email protected] or via Fax to +49 (0) 7022 704-346
Event 05.05.2017 – 07.05.2017
Kreiskliniken Esslingen gGmbH „Autoimmunity Kirchheim 2017“
Contingent number: 1164
Participant
Name and Surname:
Company:
Adress company:
Telephone number:
Faxnumber:
Emailadress:
Room reservation:
Arrival:
Departure:
Comment:
_______
Costs:
Service
accommodation 05.05. – 07.05.2017
double room incl. breakfast
accommodation 05.05. – 07.05.2017
single room incl. breakfast
Rate per room
EUR 105,00
needed
EUR 90,00
Invoice adress:
Company name
____________________________________
Contact person
____________________________________
Adress
____________________________________
Zip code / place of residence
____________________________________
Please note that the bill must be paid directly in the hotel by check in or check out. We do not send
the invoices to companies. We will use your given company address for your invoice.
Hotel Am Schlossberg GmbH & Co. KG · Tel. (07022) 7040 · Fax (07022) 704343 · [email protected] · www.hotel-am-schlossberg.de
Stuttgarter Volksbank · BLZ 600 901 00 · Kto. 389 875 007 ·IBAN DE05 6009 0100 0389 8750 07 · SWIFT/BIC VOBADESS
Sitz der Gesellschaft: Nürtingen · Amtsgericht Stuttgart A221669 · USt.-IdNr. DE146 261 516 · St.Nr. 74072/01846
Persönlich haftende Gesellschafterin: Hotel Am Schlossberg Verwaltungs-GmbH Nürtingen · Amtsgericht Stuttgart · HRB 221746
Vertreten durch GF Prof. Dr.-Ing. Rainer Stiefelhagen
BEST WESTERN Hotel Am Schlossberg · Europastraße 13 · 72622 Nürtingen
Booking guarantee:
This reservation is guaranteed by specifying the following credit card details:
Credit card number
____________________________________
Validity
____________________________________
Credit card holder
____________________________________
______________
reservation number
Reconfirmation Hotel
Confirmation Booker
____________________________
Name / Date
Signature / Stamp
_________________________
Name / Date
Signature / Stamp
BEST WESTERN
Hotel Am Schlossberg GmbH & Co. KG
Europastraße 13
72622 Nürtingen
Telephone: +49 (0) 7022 704-0
Telefax: +49 (0) 7022 704-346
[email protected]
www.hotel-am-schlossberg.de
Persönlich haftende Gesellschafterin:
Hotel Am Schlossberg Verwaltungs-GmbH
Nürtingen
Amtsgericht Stuttgart
HRB 221746
Hotel Am Schlossberg GmbH & Co. KG · Tel. (07022) 7040 · Fax (07022) 704343 · [email protected] · www.hotel-am-schlossberg.de
Stuttgarter Volksbank · BLZ 600 901 00 · Kto. 389 875 007 ·IBAN DE05 6009 0100 0389 8750 07 · SWIFT/BIC VOBADESS
Sitz der Gesellschaft: Nürtingen · Amtsgericht Stuttgart A221669 · USt.-IdNr. DE146 261 516 · St.Nr. 74072/01846
Persönlich haftende Gesellschafterin: Hotel Am Schlossberg Verwaltungs-GmbH Nürtingen · Amtsgericht Stuttgart · HRB 221746
Vertreten durch GF Prof. Dr.-Ing. Rainer Stiefelhagen
MULTIDISCIPLINARY
APPROACH TO SYSTEMIC
AUTOIMMUNE DISEASE
I would like to register for the following event:
REGISTRATION
FORM
A171-41012 Symposium Multidisciplinary Approach to Systemic Autoimmune
Disease 2017 – „Mayo Clinic Days 2017“
Date:
Location:
Costs:
booklet included)
From Friday, May 5th, 2017, 3 pm to Sunday, May 7th, 2017, 2 pm
Schlossberghalle, Dettingen, Germany
 Advance Registration (until March 01st, 2017)
EUR 149
 Late Registration (from March 1st, 2017)
EUR 190
 Employee medius KLINIKEN
EUR 145
EUR
Optional:
 Opt.1: Bus shuttle service (Best Western, Nürtingen - Dettingen)
EUR 40
EUR
Social program:  Get-together – dinner at Hotel Schwanen, Köngen, friday
EUR 50
EUR
EUR 10
EUR
EUR 60
EUR
EUR 10
EUR
(catering + abstract
Registration form
R E G E S T R AT I O N F O R M
Download as PDF: http://akademie.kk-es.de/autoimmune-conference-2017/
VASKULITISZENTRUM-SÜD
KIRCHHEIM/TECK, GERMANY
MAY 55TH
– MAY
– MAY
7, 2017
7TH, 2017
Included: a multi-course meal at Hotel Schwanen, Köngen. Excluded: drinks.
 Opt. 2: Extended bus shuttle service to the hotel
(Dettingen - Köngen - Nürtingen)
 Meet the chairmen and speakers at Burg Teck, saturday
Included: a traditional swabian meal at Burg Teck. Excluded: drinks.
 Opt. 3: Extended bus shuttle service to the parking lot
and if necessary to the hotel
(Dettingen - Teck - Dettingen - Nürtingen)
 Add on for people with physical limitations - „door to
door“ shuttle service in order to participate in the evening
event. (This service can only be used by a limited amount of people!)
Total
EUR
Last name
First name(s)
Occupation | Function
Employer
Invoice to
 private
 business
Adress
Town | Postcode
Country
Phone
E-mail
The terms and conditions
visible in the Internet apply
Date
Signature
ORGANIZER
Akademie medius KLINIKEN
Charlottenstr. 47 | D-73230 Kirchheim unter Teck
[email protected]
Fax +49 (0) 7021 88 44809
HOTEL (please book directly via the hotel)
BEST WESTERN Hotel
Am Schlossberg in Nürtingen
Keyword: „Autoimmunity Kirchheim 2017“
Contingent number: 1164
More information: http://akademie.kk-es.de/autoimmune-conference-2017/
or directly to:
[email protected]
Fax to +49 (0) 7022 704-346
39